Latest news from Medicago on Newswise en-us Copyright 2024 Newswise 115 31 / /images/newswise-logo-rss.gif /articles/preventing-a-flu-pandemic-with-just-a-single-dose-a-potential-safeguard-against-a-mutating-menace/?sc=rsin /articles/preventing-a-flu-pandemic-with-just-a-single-dose-a-potential-safeguard-against-a-mutating-menace/?sc=rsin Wed, 21 Nov 2012 09:00:00 EST Researchers found that a single dose of a vaccine being developed by Medicago, Inc., a publicly traded biopharmaceutical company, could protect against not only the avian influenza (H5N1) strain it was designed for, but also another H5N1 strain and a strain of a different flu subtype, called H2N2. Medicago